International Journal of Endocrinology and Metabolism

Published by: Kowsar

Legacy of the Tehran Lipid and Glucose Study: Chronic Kidney Disease

Anita Eftekharzadeh 1 , Farhad Hosseinpanah 1 , Majid Valizadeh 1 , * , Maryam Barzin 1 , Maryam Mahdavi 1 and Fereidoun Azizi 2
Authors Information
1 Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • International Journal of Endocrinology and Metabolism: October 2018, 16 (4 (Suppl)); e84761
  • Published Online: October 31, 2018
  • Article Type: Review Article
  • Received: September 1, 2018
  • Revised: October 2, 2018
  • Accepted: October 28, 2018
  • DOI: 10.5812/ijem.84761

To Cite: Eftekharzadeh A, Hosseinpanah F, Valizadeh M, Barzin M, Mahdavi M, et al. Legacy of the Tehran Lipid and Glucose Study: Chronic Kidney Disease, Int J Endocrinol Metab. 2018 ; 16(4 (Suppl)):e84761. doi: 10.5812/ijem.84761.

Copyright © 2018, International Journal of Endocrinology and Metabolism. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
  • 1. Hosseinpanah F, Kasraei F, Nassiri AA, Azizi F. High prevalence of chronic kidney disease in Iran: A large population-based study. BMC Public Health. 2009;9:44. doi: 10.1186/1471-2458-9-44. [PubMed: 19183493]. [PubMed Central: PMC2658666].
  • 2. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1-266. [PubMed: 11904577].
  • 3. Kestenbaum B, Rudser KD, Shlipak MG, Fried LF, Newman AB, Katz R, et al. Kidney function, electrocardiographic findings, and cardiovascular events among older adults. Clin J Am Soc Nephrol. 2007;2(3):501-8. doi: 10.2215/CJN.04231206. [PubMed: 17699457].
  • 4. Kilbride HS, Stevens PE, Eaglestone G, Knight S, Carter JL, Delaney MP, et al. Accuracy of the MDRD (modification of diet in renal disease) study and CKD-EPI (CKD epidemiology collaboration) equations for estimation of GFR in the elderly. Am J Kidney Dis. 2013;61(1):57-66. doi: 10.1053/j.ajkd.2012.06.016. [PubMed: 22889713].
  • 5. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-12. [PubMed: 19414839]. [PubMed Central: PMC2763564].
  • 6. Tohidi M, Hasheminia M, Mohebi R, Khalili D, Hosseinpanah F, Yazdani B, et al. Incidence of chronic kidney disease and its risk factors, results of over 10 year follow up in an Iranian cohort. PLoS One. 2012;7(9). e45304. doi: 10.1371/journal.pone.0045304. [PubMed: 23028919]. [PubMed Central: PMC3459968].
  • 7. Noori N, Hosseinpanah F, Nasiri AA, Azizi F. Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults. J Ren Nutr. 2009;19(3):228-37. doi: 10.1053/j.jrn.2008.11.005. [PubMed: 19261489].
  • 8. Barzin M, Hosseinpanah F, Serahati S, Salehpour M, Nassiri AA, Azizi F. Changes in waist circumference and incidence of chronic kidney disease. Eur J Clin Invest. 2014;44(5):470-6. doi: 10.1111/eci.12253. [PubMed: 24580088].
  • 9. Rashidi A, Ghanbarian A, Azizi F. Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population. Clin J Am Soc Nephrol. 2007;2(5):976-83. doi: 10.2215/CJN.01020207. [PubMed: 17702729].
  • 10. Derakhshan A, Bagherzadeh-Khiabani F, Arshi B, Ramezankhani A, Azizi F, Hadaegh F. Different combinations of glucose tolerance and blood pressure status and incident diabetes, hypertension, and chronic kidney disease. J Am Heart Assoc. 2016;5(8). doi: 10.1161/JAHA.116.003917. [PubMed: 27543801]. [PubMed Central: PMC5015306].
  • 11. Ramezankhani A, Azizi F, Ghanbarian A, Parizadeh D, Hadaegh F. The hypertriglyceridemic waist and waist-to-height ratio phenotypes and chronic kidney disease: Cross-sectional and prospective investigations. Obes Res Clin Pract. 2017;11(5):585-96. doi: 10.1016/j.orcp.2016.11.003. [PubMed: 27889358].
  • 12. Mottaghi A, Mirmiran P, Delshad H, Azizi F. Effect of different obesity phenotypes on incidence of chronic kidney disease in Tehranian adults. J Am Coll Nutr. 2016;35(7):587-96. doi: 10.1080/07315724.2015.1046195. [PubMed: 26650689].
  • 13. Hosseinpanah F, Barzin M, Golkashani HA, Nassiri AA, Sheikholeslami F, Azizi F. Association between moderate renal insufficiency and cardiovascular events in a general population: Tehran lipid and glucose study. BMC Nephrol. 2012;13:59. doi: 10.1186/1471-2369-13-59. [PubMed: 22799559]. [PubMed Central: PMC3413571].
  • 14. Panahi MH, Hadaegh F, Yavari P, Kazempour-Ardebili S, Mehrabi Y, Azizi F, et al. A Challenging interaction of chronic kidney disease with other metabolic disorders: Paradoxes in cardiometabolic risk factors. Iran J Kidney Dis. 2016;10(5):274-81. [PubMed: 27721225].
  • 15. Fahimfar N, Khalili D, Mohebi R, Azizi F, Hadaegh F. Risk factors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran. BMC Neurol. 2012;12:117. doi: 10.1186/1471-2377-12-117. [PubMed: 23031547]. [PubMed Central: PMC3517457].
  • 16. Rashidi A, Ghanbarian A, Azizi F, Adler DS. Is chronic kidney disease comparable to diabetes as a coronary artery disease risk factor? South Med J. 2007;100(1):20-6. doi: 10.1097/01.smj.0000235482.22558.a5. [PubMed: 17269521].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments